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The present study was designed to investigate the effect of early and late administration of phenylephrine 
during ischemia against regional ischemia–reperfusion injuries in an isolated rat heart model. All animals 
were randomly divided into experimental groups: (I) IR (Ischemic/ reperfusion): the hearts underwent 
35 min of regional ischemia followed by 60 min of reperfusion; (II) 5HD-IR-0: the hearts were perfused 
for 5 min with 5HD (5-hydroxydecanoate, specific mKATP channel blocker, 100 µM) at the onset of 
regional ischemia; (III) 5HD-IR-20: the hearts were perfused for 5 min with 5HD 20 min after regional 
ischemia; (IV) PE-IR-10: the hearts were perfused for 5 min with phenylephrine 10 min after regional 
ischemia; (V) PE-IR-30: the hearts were perfused for 5 min with phenylephrine (100 µM) 30 min after 
regional ischemia; (VI) PE-5HD-IR-10 group: the hearts were perfused for 5 min with 5HD at the onset of 
regional ischemia after which phenylephrine was administrated as in group IV; and (VII) PE-5HD-IR-30: 
the hearts were perfused for 5 min with 5HD 20 min after the ischemia and then phenylephrine was 
administrated as in group V. The hemodynamic parameters were recorded throughout the experiment. 
Ischemia-induced arrhythmias, myocardial infarct size (IS), creatin kinase-MB isoenzyme (CK-MB), 
plasma lactate dehydrogenase (LDH) activities, and coronary blood flow (CBF) were measured in all 
animals. Perfusion of phenylephrine 30 min after the regional ischemia curtailed the myocardial infarct 
size, reduced CK-MB, and improved cardiac function and CBF. Administration of 5HD 30 min after the 
ischemia abolished cardioprotective effects of phenylephrine in the late phase. These results suggest the 
involvement of mKATP in the mechanism of phenylephrine-induced late preconditioning.
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INTRODUCTION
Brief periods of ischemia lead to reduced severity 
of cardiac injury following a second sustained period of 
ischemia. This cardioprotective effect has been termed 
ischemic preconditioning (Tonkovic-Capin et al., 
2002). Local preconditioning cannot be used in acute 
clinical settings such as acute myocardial infarction, 
ischemic stroke, or acute major vascular occlusion. 
It, therefore, has become necessary to develop new 
techniques suitable for providing protection against 
unpredictable ischemic events. One option is modifying 
the reperfusion period by means of brief coronary artery 
occlusions and reperfusions applied at the onset of 
myocardial reperfusion, a phenomenon called ischemic 
postconditioning (IPOST). Although Na et al. (1996) 
formulated the seminal idea and terminology, the first 
easily reproducible experimental results on this topic 
were published by Zhao et al. (2003).
A shortcoming of both preconditioning and 
postconditioning is lengthened operative time, possibly 
even for duration of 15-20 min. A further negative 
aspect is that in the presence of atherosclerosis, these 
invasive techniques can lead to serious, life-threatening 
complications such as plaque rupture.
The role of α1-adrenoceptors has been studied 
extensively for the early preconditioning. Pharmacological 
activation of α1-adrenoceptors has been shown to mimic 
early preconditioning (Rojas Gomez et al., 2008; Salvi, 
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2001) and its blockade nullifies the cardioprotective effect 
of preconditioning (Piascik, Perez, 2001) .
Early studies have suggested that stimulation of 
a1-adrenoceptors is one of the essential triggers of the 
early phase of ischemic preconditioning (Banerjee et al., 
1993). Also, exogenous activation of a1-adrenoceptor can 
exert both early (Imani et al., 2008; Salvi, 2001) and late 
preconditioning (Kudej et al., 2006; Tejero-Taldo et al., 
2002). In those studies, the preconditioning stimulus was 
administered before the onset of myocardial ischemia.
A l t h o u g h  t h e  t r i g g e r s  a n d  m e d i a t o r s  o f 
perconditioning are still not well understood, some studies 
have revealed that stimulation of α1-adrenoceptors is one 
of the essential triggers of the early phase of ischemic 
preconditioning (Banerjee et al., 1993). In addition, some 
studies have indicated that activation of α1-adrenoceptors 
can induce both early (Rojas Gomez et al., 2008; Salvi, 
2001) and late preconditioning (Naderi et al., 2010b). 
It has been shown that mitochondrial ATP-
sensitive K channels (mKATP) have a great influence 
on cardioprotection afforded by preconditioning 
(Rajesh et al., 2004; Tonkovic-Capin et al., 2002).
In this regard, diazoxide, as a specific opener 
of  the  mKATP channe ls ,  can  mimic  i schemic 
preconditioning (Shen et al., 2004), with application 
of 5HD (5-hydroxydecanoate), as a putatively specific 
mKATP channel blocker, preventing the cardioprotective 
effect of ischemic preconditioning (Tsukamoto et al., 
2005) or pharmacological preconditioning. However, it 
has been suggested that the mKATP channels are involved 
as a subcellular mediator in preconditioning afforded by 
α1-adrenoceptor activation (Cohen et al., 2001; Gao, Chen, 
Yang, 2007), but the role of this channel in phenylephrine-
induced late preconditioning is still unknown.  
The present study was designed to investigate the 
effect of early and late administration of phenylephrine 
during ischemia against regional ischemia–reperfusion 
injuries in an isolated rat heart model. We also examined 
the role of the mKATP channels in this form of myocardial 
protection.
MATERIAL AND METHODS  
Preparation of Isolated Hearts
Male Wistar rats (200–250 g) were housed in an 
air-conditioned colony room on a light/dark cycle at 
21-23 ºC with free access to food and water. The animals 
were anesthetized by sodium pentobarbital (60 mg/kg, 
i.p.) and given heparin sodium (500 IU). The hearts were 
rapidly excised and placed in ice-cold buffer, and mounted 
on a constant pressure (80 mmHg) Langendorff-perfusion 
apparatus. All experiments were conducted in accordance 
with the institutional guidelines of Lorestan University 
of Medical Sciences (Khorramabad, Iran) as well as 
the National Institutes of Health guidelines for the care 
and use of laboratory animals. The hearts were perfused 
retrogradely with modified Krebs-Henseleit bicarbonate 
buffer containing (in mmol/L): NaHCO3 25; KCl 4.7; 
NaCl 118.5; MgSO4 1.2; KH2PO4 1.2; glucose 11; CaCl2 
2.5 gassed with 95% O2/5% CO2 (pH 7.35–7.45 at 37 ºC). 
A latex, fluid-filled, isovolumic balloon was introduced 
into the left ventricle through the left atrial appendage and 
inflated to give a preload of 8 to 10 mmHg while connected 
to a pressure transducer (Harvard, March-Hugsteten, 
Germany). Two thin stainless steel electrodes fixed at the 
ventricular apex and right atrium were employed to record 
ECG for monitoring the heart rate.
A surgical needle was passed under the origin of the 
left anterior descending coronary artery, while the ends 
of the suture were passed through a pipette tip to form a 
snare. Regional ischemia was induced by tightening the 
snare and reperfusion was performed by releasing the ends 
of the suture. The perfusion apparatus was water-jacketed 
to maintain a constant perfusion temperature of 37 ºC. The 
hearts were allowed to beat spontaneously throughout the 
experiments. Hemodynamic parameters [left ventricular 
developed pressure and heart rate] were continuously 
monitored and recorded throughout the experiment using 
a computerized data acquisition system (ML750 Power 
Lab/4sp, AD Instruments) (Moghimian et al., 2014).
Left ventricular hemodynamic parameters including 
left ventricular end-diastolic pressure (LVEDP), left 
ventricular developed pressure [LVDP = LVSP (left 
ventricular systolic pressure) − LVEDP], maximum rise and 
fall of LV pressures (+dp/dt and −dp/dt, respectively), and 
RPP (rate pressure product = LVDP × HR) were recorded 
at 10 min after termination of reperfusion. Also, coronary 
effluent was collected for CK-MB (Creatine KinaseMB) and 
LDH (lactate dehydrogenase) measurements. 
Experimental protocol
Following heart isolation and prior to the baseline 
period, all hearts were perfused and allowed to stabilize 
for 30 min within which the heart rate and left ventricular 
developed pressure were maintained at the same level for 
three continuous measurement periods timed 5 min apart. 
The experimental design is illustrated in Figure 1. All 
animals were randomly divided into experimental groups 
(n= 6-10) as follows: (I) IR (Ischemic/ reperfusion) group: 
the hearts underwent 35 min of regional ischemia followed 
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by 60 min reperfusion; (II) 5HD-IR-0 group: the hearts 
were perfused for 5 min with 5HD (5-hydroxydecanoate, 
specific mKATP channel blocker, 100 µM) at the onset 
of regional ischemia; (III) 5HD-IR-20 group: the hearts 
were perfused for 5 min with 5HD (100 µM) 20 min after 
regional ischemia; (IV) PE-IR-10 group: the hearts were 
perfused for 5 min with phenylephrine (100 µM) 10 min 
after regional ischemia; (V) PE-IR-30 group: the hearts 
were perfused for 5 min with phenylephrine (100 µM) 
30 min after regional ischemia; (VI) PE-5HD-IR-10 group: 
the hearts were perfused for 5 min with 5HD (100 mM) at 
the onset of regional ischemia and then phenylephrine was 
administrated as in group IV; (VII) PE-5HD-IR-30 group: 
the hearts were perfused for 5 min with 5HD (100 mM) 
20 min after regional ischemia and then phenylephrine 
was administrated as in group V.
Administrations of drugs in the early phase were 
performed via the second arm of perfusate cannula 
which was connected to the main perfusion cannula. The 
experimental conditions were constant throughout the 
experiment.
Infarct size measurement
Once the reperfusion period was completed, the 
hearts were frozen overnight and then sliced into 2-mm 
transverse sections from apex to base. The slices were 
then incubated with triphenyl tetrazolium chloride 1% 
(TTC in phosphate buffer 0.1 M, pH=7.4) for a period 
of 20 min at 37 °C. TTC reacted with the viable tissue, 
producing a red formazan derivative, which was distinct 
from the white necrotic tissue once fixed in formalin 10% 
for 24 h. The areas of the left ventricle and infracted tissues 
were measured through planimetry of the scanned hearts 
using Photoshop program. The volumes were obtained 
via multiplying the area by the thickness of the slices. 
The infarct size was expressed as the percentage of left 
ventricular volume for each heart (IS/LV).
Determination of arrhythmia scores
During the 30-min ischemia, ventricular arrhythmias 
were evaluated according to Lambeth convention 
(Walker et al., 1988). 
Ventricular ectopic beats (VEBs) were defined 
as identifiable premature QRS complexes. Ventricular 
tachycardia (VT) was defined as a run of four or more 
ventricular premature beats. Finally, ventricular fibrillation 
(VF) was defined as the signal for which individual QRS 
deflections can no longer be distinguished from one other 
and the rate can no longer be measured. Original ECG 
recordings are illustrated in Figure 2. The onset time 
and duration of arrhythmias were captured to identify 
the severity of arrhythmias according to the following 
scoring system (Curtis, Walker, 1988). 0: <10 ventricular 
premature beats, 1: ≥10 ventricular premature beats, 2: VT 
(duration <30 s), 3: VT (duration ≥30 s), 4: VF starting 
15 min after the onset of ischemia, 5: VF starting 5-15 min 
after the onset of ischemia, 6: VF starting within 5 min 
after the onset of ischemia.
Biochemical analysis
The activity of CK-MB and LDH was calculated 
in coronary effluent samples at the end of reperfusion 
by commercial kits (Pars Azmoon, Iran) employing 
an autoanalyzer (Roche Hitachi Modular DP Systems, 
Mannheim, Germany). 
FIGURE 1 - Schematic illustration of the experimental groups: 
5HD (5 hydroxydecanoate); PE (phenylephrine).
FIGURE 2 - Electrocardiogram recording; (A) During baseline; 
(B) during coronary artery occlusion; (C) ventricular ectopic 
beat (VEB); (D) couplet; (E) bigeminy; (F) ventricular 
tachycardia (VT); and (G) ventricular fibrillation (VF).
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Measuring the coronary blood flow
The microvascular blood flow in the myocardium 
was recorded at the baseline, after 35 min of regional 
ischemia (ischemic myocardium), and after 60 minutes of 
reperfusion (reperfused myocardium), using laser Doppler 
flowmeter (ML191, Blood Flowmeter, AD Instruments). 
The data were expressed as the mean percentage of the 
baseline preischemia value.
Chemicals
Phenylephrine, 5HD, and triphenyltetrazolium 
chloride (TTC) were obtained from Sigma-Aldrich 
(Deisinhofen, Germany) and general laboratory chemicals 
were acquired from Merck (Darmstadt, Germany). 
Stock solutions of phenylephrine and 5HD were diluted 
with distilled water and added to the Krebs’–Henseleit 
bicarbonate (KHB) buffer and equilibrated with O2(95%)–
CO2 (5%) (pH=7.4 at 37 ºC).
Statistical analyses
The data have been expressed as means ±S.E.M. The 
statistical comparison of means between the groups was 
made by one-way ANOVA followed by Tukey test. The 
significant differences were determined as P<0.05.
RESULTS
Hemodynamic function
The results in Table I indicate HR, LVDP, and 
rate pressure product (RPP as the percentage of an 
individual baseline). Since HR and LVDP may recover 
to different degrees, the rate pressure product was 
calculated through multiplying the heart rate by left 
ventricular developed pressure and presented as a 
reliable left ventricular function parameter for the 
isolated heart.
There were significant differences between RPP 
at the baseline and end of reperfusion (p<0.05). The 
results revealed that administration of phenylephrine in 
phenylephrine-late perconditioning (PE-IR-30) group 
increased the recovery of RPP at the end of reperfusion 
in comparison with the IR group (p<0.05). The increased 
RPP by PE at late perconditioning was nullified by 
pretreatment with 5HD in 5HD-PE-IR-30 group as 
compared to PE-IR-30 (p<0.05).
Infarct size and area at risk
Figure 3 demonstrates the original pictures of 
TTC staining of the heart, with Figure 3B illustrating 
the ratio of the infarct size to the total left ventricular 
area. The ratio of infarct size to the total left ventricular 
area decreased considerably from 40.8±3.7 in ischemia/
reperfusion group to 22.8±3.4 in phenylephrine-late 
perconditioning (PE-IR-30) group. The reduction in the 
infarct size by PE at late perconditioning was nullified 
by pretreatment with 5HD in 5HD-PE-IR-30 group as 
compared to PE-IR-30 (35.4 ± 3 % vs. 22.8 ±3.4 %). 
Our data analysis showed no significant differences in 
the infarct size between the other groups. 
TABLE I - Hemodynamic parameters. HR (heart rate, beat per minute); LVDP (left ventricular developed pressure); RPP  (rate 
pressure product) (beats/min mmHg × 103) in ischemia/reperfusion (IR), 5HD perfused at the onset of regional ischemia (5HD-
IR-0), 5HD perfused 20 min after regional ischemia (5HD-IR-20), phenylephrine-early perconditioning 10 min after ischemia 
(PE-IR-10), phenylephrine-late perconditioning 30 min after ischemia (PE-IR-30), 5HD-phenylephrine-early perconditioning 
(5HD-PE-IR-10), 5HD-phenylephrine-late perconditioning (5HD-PE-IR-30).
Group
Baseline End of ischemia End of reperfusion
HR 
(bpm)
LVDP 
mmHg
RPP 
bpm.mmHg
HR 
(bpm)
LVDP 
mmHg RPP %
HR 
(bpm)
LVDP 
mmHg RPP %
IR 289±23 82±5.1 24057±3572 273±19 59±10 42±8.8 245±15& 50±14& 46±6.2&
5HD-IR-0 285±27 99±17 27279±4914 264±24 49.7±6 48.8±10 239±29& 58.5±10.5& 44±13.5&
5HD- IR-20 287±15.7 90±6.3 25919±773.1 235±17.1 39±4.6   57±7.4 246±17.4& 50±3.1& 48±1.4&   
PE- IR-10 290±28 83±7.1 24386±3290 230±27 63±11 45±10.4 239±24& 75.5±5.4& 65±7.9&
PE- IR-30 300±15 90±6.7 27042±2726 233±25 70±6.9 67±6.1 230±24& 71±9.8& 78±3.8*#&
5HD-PE-IR-10 253±13.9 89.2±7.8 22478±1132 212+9 76±7.7 57±6.8 213.5±8.8& 81±2.5 & 51.5±3.1&
5HD-PE-IR-30 266±28 92±6 24493±2635 234±21 70±16 51.6±9.4 205±12& 68.5±7.3& 47±10&
Repeated measure ANOVA was performed for inter- and intragroup comparisons. &P<0.05 vs. baseline. * P<0.05 vs. IR group. # 
P<0.05 vs. PE-5HD-IR-30 group. The data are presented as mean±SEM.
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LDH and CK-MB activity
LDH and CK-MB levels in the coronary artery 
effluent considerably declined by phenylephrine-induced 
perconditioning in the late phase (PE-IR-30) compared 
with ischemia/reperfusion group at 60 min (6.8 ± 2.8, 
2.5 ± 0.86 versus 24 ± 4.5, 4.4 ± 0.74, respectively) 
after reperfusion. Addition of 5HD prior to PE restored 
the levels of LDH and CK-MB as seen in ischemia/
reperfusion group in 5HD-PE-IR-30 at 60 min (24.2 ± 5.5 
and 4.7 ± 0.8) after reperfusion (Figure 4A and B). Our 
data analysis showed no significant differences in LDH 
and CK-MB levels between the other groups. 
Severity of arrhythmias
Administration of PE, 30 min after the onset of 
ischemia (PE-IR-30) (2 ± 0.75) significantly reduced 
the severity of ventricular arrhythmias compared to IR 
(4.2 ± 1.1) and PE-IR-10 (3.85 ± 0.67) groups. Addition 
of 5HD prior to PE in 5HD-PE-IR-30 (4 ± 0.8) group 
intensified the severity of arrhythmias compared to 
PE-IR-30 (Figure 5).
Number of PVC, VT and VF episodes 
The mean number of PVC episodes during 30 min 
of ischemia in the PE-IR-30 group (16 ± 6.6) was 
diminished considerably, compared with IR (63.8 ± 13.8) 
and PE-IR-10 (55 ± 9) groups. Addition of 5HD prior to 
PE in 5HD-PE-IR-30 (50 ± 13.8) enhanced the number 
of PVC episodes, as compared to PE-IR-30 (Figure 6A). 
Further, the administration of PE, 30 min after the onset of 
ischemia (PE-IR-30) (0.14 ± 0.14) significantly declined 
the number of VF episodes compared to IR (2 ± 0.9) group. 
Also, 5HD prior to PE in 5HD-PE-IR-30 (1.6 ± 0.7) group 
enhanced the number of VF compared to PE-IR-30 (Figure 
FIGURE 3 - A - The original pictures of TTC staining heart 
slices. 5HD, 5 hydroxydecanoate. B - The ratio of infarct size 
to total left ventricular area (IS/LV%) in ischemia/reperfusion 
(IR), 5HD perfused at onset of regional ischemia (5HD-IR-0), 
5HD perfused 20 min after regional ischemia (5HD-IR-20), 
phenylephrine-early perconditioning 10 min after ischemia 
(PE-IR-10), phenylephrine-late perconditioning 30 min after 
ischemia (PE-IR-30), 5HD-phenylephrine Early perconditioning 
(5HD-PE-IR-10), 5HD-phenylephrine-late perconditioning 
(5HD-PE-IR-30) groups. Data are presented as Mean ±S.E.M. 
Significant difference with IR group (P<0.05) *. Significant 
difference with PE-IR-30 group (P<0.05) &. 
FIGURE 4 - A - Level of LDH and B - CK-MB in coronary 
effluent in 60 min after reperfusion in ischemia/reperfusion 
(IR), 5HD perfused at onset of regional ischemia (5HD-IR-0), 
5HD perfused 20 min after regional ischemia (5HD-IR-20), 
phenylephrine-early perconditioning 10 min after ischemia 
(PE-IR-10), phenylephrine-late perconditioning 30 min after 
ischemia (PE-IR-30), 5HD-phenylephrine Early perconditioning 
(5HD-PE-IR-10), 5HD-phenylephrine-late perconditioning 
(5HD-PE-IR-30) groups. Data are presented as mean±SEM. 
Significant difference with IR group (P<0.05) *. Significant 
difference with PE-IR-30 group (P<0.05) &.
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6C). There were no significant differences of the number 
of VT episodes between the experimental groups.
Assessing coronary blood flow
Coronary blood flow measured using LDF decreased 
by at least 60% after ischemia in all animals. Laser 
Doppler assessment of blood flow indicated a significant 
improvement of perfusion in the PE-IR-30 at the end of 
ischemia and reperfusion period. Addition of 5HD prior to 
PE lowered the LDF (Figure 7). There was no statistically 
significant difference in LDF between the other groups. 
There were no significant differences of BSC between the 
experimental groups either.
DISCUSSION
The present study indicated that perfusion of 
phenylephrine (as an a1-adrenoceptor agonist) in the 
late phase, 30 min after regional ischemia, decreased 
myocardial infarct size (% of ischemia zone), reduced 
creatine kinase-MB (CK-MB) in the coronary effluent, 
and improved cardiac function. Administration of 5HD 
(5-hydroxydecanoate) as a putatively specific blocker 
of the mitochondrial KATP channels 30 min after the 
regional ischemia nullified the cardioprotective effects of 
phenylephrine in the late phase and brought the infarct size, 
FIGURE 5 - Distribution of the arrhythmia score (severity) 
during 35 min ischemia in ischemia/reperfusion (IR), 5HD 
perfused at onset of regional ischemia (5HD-IR-0), 5HD 
perfused 20 min after regional ischemia (5HD-IR-20), 
phenylephrine-early perconditioning 10 min after ischemia 
(PE-IR-10), phenylephrine-late perconditioning 30 min after 
ischemia (PE-IR-30), 5HD-phenylephrine Early perconditioning 
(5HD-PE-IR-10), 5HD-phenylephrine-late perconditioning 
(5HD-PE-IR-30) groups. Data are presented as mean ± SEM. * 
P < 0.05 vs. IR.  # P < 0.05 vs.  PE-IR-10 group. & P < 0.05 vs. 
PE-IR-30 group. 
FIGURE 6 - A - episode  number  of  PVC (premature ventricular 
contraction), B - episode  number  of  VT  (ventricular 
tachycardia) and C - VF  (ventricular  fibrilation)  during 30 
min  ischemia  in  ischemia/reperfusion (IR), 5HD perfused 
at onset of regional ischemia (5HD-IR-0), 5HD perfused 20 
min after regional ischemia (5HD-IR-20), phenylephrine-
early perconditioning 10 min after ischemia (PE-IR-10), 
phenylephrine-late perconditioning 30 min after ischemia 
(PE-IR-30), 5HD-phenylephrine Early perconditioning (5HD-
PE-IR-10), 5HD-phenylephrine-late perconditioning (5HD-PE-
IR-30) groups. Data are presented as mean ± SEM.  *P < 0.05 
vs IR.  # P < 0.05 vs.  PE-IR-10 group. & P < 0.05 vs.  PE-IR-30 
group.
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CK-MB and cardiac function to levels already observed 
in the ischemia/reperfusion group. Therefore, this result 
suggests involvement of mKATP in the mechanism of 
phenylephrine-induced late perconditioning.
In an early study, we also observed the contribution 
of mitochondrial ATP-sensitive potassium channel 
(mKATP) in protecting phenylephrine-induced early and 
late preconditioning in an isolated rat heart (Naderi, Imani, 
Faghihi, 2010a) . 
T h e  n o v e l t y  o f  t h i s  s t u d y  i s  t h a t  t h e 
<alpha>1-adrenoceptor agonist was administered 
during regional ischemia (perconditioning model). Our 
study indicated that the pharmacological stimulation of 
the α1-adrenoceptors induced cardioprotection in the 
isolated rat heart when administered 30 min after the 
regional ischemia. However, applying pharmacological 
stimulation of the α1-adrenoceptors 10 min after the 
ischemia cannot induce the same effects. In the current 
experiment, phenylephrine administered 30 min after the 
onset of ischemia improved contractile function, reduced 
incidence of VT, and modified biochemical parameters 
in the same direction with the infarct size. We observed 
that phenylephrine after 30 min of ischemia attenuated 
heart function loss at the end of ischemia and reperfusion 
period, and caused a significant increase in RPP. The 
major effects of cardioprotection include reduced infarct 
size (anti-necrotic effect) (Ondrejcakova et al., 2009), 
lowered number and severity of cardiac arrhythmias 
(anti-arrhythmic effect) (Banerjee et al., 1993; Headrick, 
1996), and improved contractile function (protection 
against contractile dysfunction) (Tsuchida et al., 1994). 
Elevated levels of CK have also been regarded as a specific 
biochemical marker of myocyte necrosis (Yilmaz et al., 
2006). Further, LDH level plays an important role in 
systemic tissue damage (Devi et al., 2005). The effects 
of phenylephrine on releasing CK-MB and LDH were 
nullified by 5HD. The differences between phenylephrine 
administration at 10 or 30 min after ischemia might be 
related to the influence of beta-receptor stimulation. The 
possible role of concentration, protein binding (95%) 
and half-life of phenylephrine should also be considered. 
In addition, we observed that phenylephrine would 
stimulate microvascular blood flow in the myocardium and 
increase LDF, suggesting that its protect the myocardium 
from ischemia-reperfusion injury by preventing post-
ischemic fall in blood flow. Enhancing blood flow to 
the myocardium is the aim of any form of treatment of 
ischemic heart disease.
Some experimental data have revealed that general 
activation starting 24 h after an ischemic event promotes 
the functional outcome without increasing tissue loss 
(Johansson, Ohlsson, 1996; Ohlsson, Johansson, 1995). 
One study indicated that preconditioning induced by 
intermittent limb ischemia administered after the onset of 
established myocardial ischemia and before reperfusion 
induced protection against myocardial dysfunction, 
malignant arrhythmia, and MI, through a KATP channel-
dependent mechanism (Schmidt et al., 2007). It is 
postulated that opening of mKATP could lead to mPTP 
inhibition via reducing mitochondrial Ca2+ load, enhancing 
mitochondrial energy production, or releasing ROS 
(Hausenloy et al., 2002).
It has also been demonstrated that there is a 
close relationship between the activity of Bcl-2 as an 
antiapoptotic protein and mPTP inhibition during late 
ischemic preconditioning (Rajesh et al., 2003). The 
inhibition of the mitochondrial permeability transition pore 
(mPTP) due to stimulation of α1-adrenoceptor is thought 
to be mediated by facilitated release of antiapoptotic 
proteins including Bcl-2 and activation of mKATP channel 
(Naderi et al., 2010b).
In this study, the use of 5HD 30 min after the 
onset of ischemia rendered phenylephrine-induced 
cardioprotection ineffective in the late phase (late 
percondioning), suggesting that its effects are mediated, 
at least in part, by a KATP channel-dependent mechanism. 
Similarly, in our previous study, addition of 5HD reversed 
the protective effect of phenylephrine on hemodynamic 
FIGURE 7 - The coronary blood flow (CBF) was recorded, 
at baseline, after 35 min of regional ischemia (ischemic 
myocardium), and after 60 minutes of reperfusion (reperfused 
myocardium), by using laser Doppler flowmeter LDF in 
ischemia/reperfusion (IR), 5HD perfused at onset of regional 
ischemia (5HD-IR-0), 5HD perfused 20 min of regional ischemia 
(5HD-IR-20), phenylephrine-early perconditioning 10 min 
of ischemia (PE-IR-10), phenylephrine-late perconditioning 
30 min of ischemia (PE-IR-30), 5HD-phenylephrine Early 
perconditioning (5HD-PE-IR-10), 5HD-phenylephrine-late 
perconditioning (5HD-PE-IR-30). Repeated measure ANOVA 
was performed to compare between and within groups. 
* P<0.05 vs. IR group & P<0.05 vs. PE-IR-30 group. Data were 
expressed as a mean percentage of the baseline preischemia value.
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parameters in early and late phases (Naderi, Imani, 
Faghihi, 2010a). These findings support the hypothesis 
that perconditioning utilizes a similar pathway, though 
experiments at the cellular level are required. As an 
example, under similar experimental settings, some 
experiments have shown that phenylephrine regulates 
mitochondrial membrane potential.
CONCLUSIONS 
This study is the first to show that phenylephrine 
can induce late perconditioning via activating the mKATP 
opening in an isolated rat heart.
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